Drawing for INC RESEARCH

USPTO serial 85138041

INC RESEARCH

Reviewed by CopyMark Law Group

Reg. 3961733Status 710
Filing date
Status date
Registration date
May 17, 2011
Examiner
PARADEWELAI, BENJI YUEN
Law office
TMEG LAW OFFICE 101

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with INC RESEARCH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Stephen C. Barsotti

Stephen C. Barsotti Kegler Brown Hill & Ritter Co., Inc.65 East State StreetSuite 1800Columbus, OH 43215

Goods and services

ClassDescriptionStatusFirst use
009DOWNLOADABLE ELECTRONIC PUBLICATIONS IN THE NATURE OF NEWSLETTERS AND BULLETINS IN THE FIELD OF MEDICAL TECHNOLOGY, BIOTECHNOLOGY AND PHARMACEUTICAL RESEARCHSECTION 8 - CANCELLEDJun 1, 2002
041PROVIDING ON-LINE, NON-DOWNLOADABLE NEWSLETTERS AND BULLETINS IN THE MEDICAL TECHNOLOGY, BIOTECHNOLOGY AND PHARMACEUTICAL FIELDSSECTION 8 - CANCELLEDJun 1, 2002
042MEDICAL, SCIENTIFIC AND DATA ANALYSIS RESEARCH SERVICES FOR OTHERS, NAMELY, CONDUCTING AND ANALYZING CLINICAL TRIALS IN THE MEDICAL TECHNOLOGY, BIOTECHNOLOGY AND PHARMACEUTICAL FIELDS; PHARMACEUTICAL DRUG DEVELOPMENT SERVICES, NAMELY, DEVELOPING CLINICAL TRIAL METHODOLOGIES; CONSULTING SERVICES IN THE AREA OF PHARMACEUTICAL CLINICAL TESTINGSECTION 8 - CANCELLEDJan 1, 1998

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 19, 2021CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
May 17, 2020REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
May 1, 2019ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Apr 3, 2019ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Nov 14, 2017ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 14, 2017REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 2, 2017NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jul 2, 2017C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jul 2, 2017APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 8, 2017E815TEAS SECTION 8 & 15 RECEIVED—
May 27, 2015ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Nov 19, 2014ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Apr 25, 2012ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Jul 20, 2011ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
May 17, 2011R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 1, 2011NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 1, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 25, 2011PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 25, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 21, 2011XAECEXAMINER'S AMENDMENT ENTERED—
Jan 21, 2011ALIEASSIGNED TO LIE—
Jan 20, 2011GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 20, 2011GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 20, 2011CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 10, 2011GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 10, 2011GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 10, 2011CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 3, 2011DOCKASSIGNED TO EXAMINER—
Sep 29, 2010NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 28, 2010NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance